MoneyWorks4Me

Suven Life Sciences - Quaterly Results

13 Aug 2025 Evaluate
An increase of about 85.59% to Rs. 18.67 millions in the topline was observed for the quarter ended June 2025. The topline stood at Rs. 10.06 millions during the similar quarter previous year.The Net Loss for the quarter ended June 2025 is Rs. -147.78 millions as compared to Net Loss of Rs. -76.66 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 further decreased to -134.10% as compared to -61.57% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 18.67 10.06 85.59 18.67 10.06 85.59 66.56 116.93 -43.08
Other Income 5.89 39.31 -85.02 5.89 39.31 -85.02 107.26 211.30 -49.24
PBIDT -134.10 -61.57 117.80 -134.10 -61.57 117.80 -412.11 -98.07 320.22
Interest 0.00 0.23 0.00 0.00 0.23 0.00 0.47 1.58 -70.25
PBDT -134.10 -61.80 116.99 -134.10 -61.80 116.99 -412.58 -25.08 1545.06
Depreciation 13.68 14.86 -7.94 13.68 14.86 -7.94 58.22 65.02 -10.46
PBT -147.78 -76.66 92.77 -147.78 -76.66 92.77 -470.80 -90.10 422.53
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -10.02 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -147.78 -76.66 92.77 -147.78 -76.66 92.77 -470.80 -80.08 487.91
Equity 218.07 218.07 0.00 218.07 218.07 0.00 218.07 218.07 0.00
PBIDTM(%) -718.26 -612.03 17.36 -718.26 -612.03 17.36 -619.16 -83.87 638.23
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..